Answers are grounded in this paper and cite their sources.
Multidrug-resistant (MDR) pathogens pose a major global threat to public health, creating an urgent demand for natural antimicrobial agents. This study evaluated the bioactive potential of Cassia sophera against pathogenic bacteria and fungi and conducted phytotoxicity assays using rice seeds. To identify potential C. sophera -derived inhibitors targeting CTX-M-9 β-lactamase, we used computational approaches. In vitro antibacterial assays revealed that the methanolic extract exhibited the highest inhibitory activity against Escherichia coli , with an inhibition zone of 25.79 ± 0.32 mm. The highest antifungal activity was observed against Fusarium concentricum with 41.97–45.38% and F. fujikuroi with 40.02–41.99% inhibition. The highest seed germination rate was observed at 95.55% in the methanolic extract of C. sophera. Molecular docking (MD) studies demonstrated stronger binding affinities for CID 624791 (-8.0 kcal/mol) and CID 5304778 (-7.2 kcal/mol) with the CTX-M-9 β-lactamase (PDB ID: 1YLY), outperforming the reference Ceftazidime (-7.0 kcal/mol). ADME and toxicity analyses indicated that the leading compounds have favorable pharmacokinetic profiles with low predicted toxicity. During 100 ns MD simulations, both compounds maintained stable conformational behavior. MM-PBSA and DFT analysis revealed CID 624791 as a potential candidate with a binding free energy of − 25.56 ± 2.54 kcal/mol. Overall, the integrated experimental and computational findings highlight the antimicrobial potential of C. sophera extracts and identify CID 624791 as a promising computational candidate for further experimental validation as a potential CTX-M-9 β-lactamase inhibitor.
No takes yet. Share an insight, caveat, or question.
Hossan et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: